Dr. Kent Holtorf, MD

Bio

Specialties:

  • endocrinology/diabetes/metabolism

Affiliation:

  • Holtorf Medical Group

Location:

  • Torrence, CA

Activity

  • Sharecare News
    Sharecare News posted a story about Gastroenterology:

    WEDNESDAY, Feb. 25, 2015 (HealthDay News) -- A common ingredient in many processed foods might increase the risk of inflammatory bowel disease (IBD) and metabolic syndrome, a new study in mice suggests.

    Emulsifiers are used to improve food texture and to extend shelf life. In experiments ...Full Article

  • Sharecare News
    Sharecare News posted a story about Dentist:

    WEDNESDAY, Feb. 25, 2015 (HealthDay News) -- A British study finds a correlation between the amount of fluoride in public drinking water and a rise in incidence of underactive thyroid.

    While the study is only able to establish an association, not cause-and-effect, experts say the link des...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    MONDAY, Feb. 23, 2015 (HealthDay News) -- People with low levels of vitamin D appear to have an increased risk for type 2 diabetes, even if they aren't overweight or obese, a new study suggests.

    The study included almost 150 people in Spain. Their vitamin D leve...Full Article

  • Sharecare News
    Sharecare News posted a story about Ophthalmology:

    WEDNESDAY, Feb. 18, 2015 (HealthDay News) -- A vision-robbing condition called diabetic macular edema can strike people with diabetes.

    Now, a new study compared three leading drugs for the condition -- Avastin, Eylea and Lucentis -- and found that Eylea came out on top, at least for pati...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    THURSDAY, Feb. 19, 2015 (HealthDay News) -- A new study helps explain why getting too little sleep might boost diabetes risk.

    Researchers say lack of sleep can lead to increased levels of substances called free fatty acids in the blood. These substances interfere with the ability of the ...Full Article

  • Sharecare News
    Sharecare News posted a story about Pediatric Endocrinology:

    TUESDAY, Feb. 17, 2015 (HealthDay News) -- The care of type 1 diabetes has evolved rapidly over the past few decades, but not all racial and ethnic groups seem to be benefiting from the latest treatments, a new study indicates.

    The researchers found that black children with type 1 diabet...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    MONDAY, Feb. 16, 2015 (HealthDay News) -- Women whose mothers smoked while pregnant may be two to three times more likely to develop diabetes as adults, new research suggests.

    The finding is based on the tracking of 1,800 women whose mothers had been participant...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    FRIDAY, Feb. 13, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved a new drug to treat progressive thyroid cancer that continues to worsen despite radioactive iodine therapy.

    Results of a just-published clinical trial found that the oral drug Lenvima (lenva...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    FRIDAY, Feb. 13, 2015 (HealthDay News) -- Lenvima (lenvatinib) has been approved by the U.S. Food and Drug Administration to treat differentiated thyroid cancer (DTC) that has progressed despite radioactive iodine therapy, the agency said Friday in a news release.

    DTC is the most common t...Full Article

  • Sharecare News
    Sharecare News posted a story about Oncology:

    THURSDAY, Feb. 12, 2015 (HealthDay News) -- A new thyroid cancer drug can delay the progression of the disease almost five times longer than a placebo in people with recurring cancer, according to results from a new clinical trial.

    The oral drug, lenvatinib, is a targeted therapy that fig...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    TUESDAY, Feb. 10, 2015 (HealthDay News) -- Adults who had low vitamin D levels as children and teens may be more likely to have hardening of the arteries, a new study suggests.

    Artery hardening is associated with heart disease.

    The study included more than 2,100 people in Finland...Full Article

  • Sharecare News
    Sharecare News posted a story about Cardiology:

    TUESDAY, Feb. 10, 2015 (HealthDay News) -- A new analysis shows that people with type 2 diabetes are less likely to suffer heart attacks, strokes or die early when they take blood pressure medications -- even if they don't actually have high blood pressure.

    "Stroke, heart attack and othe...Full Article

  • Sharecare News
    Sharecare News posted a story about Pediatrics:

    MONDAY, Feb. 9, 2015 (HealthDay News) -- Energy drinks are linked to hyperactivity and inattention in middle-school students, a new study reveals.

    Yale University researchers looked at more than 1,600 students at middle schools in one urban school district in Connecticut. Their average a...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    MONDAY, Feb. 9, 2015 (HealthDay News) -- A drug to treat the most common eye disease among diabetics has been approved by the U.S. Food and Drug Administration.

    Lucentis (ranibizumab) has been sanctioned to treat diabetic retinopathy, the leading cause of blindness among adults in the Uni...Full Article

  • Sharecare News
    Sharecare News posted a story about Endocrinology/diabetes/metabolism:

    FRIDAY, Feb. 6, 2015 (HealthDay News) -- The U.S. Food and Drug Administration on Friday approved the drug Lucentis (ranibizumab) to treat diabetic retinopathy in patients with diabetic macular edema.

    A leading cause of blindness among adults in the United States, diabetic retinopathy is ...Full Article